ELEM Biotech
Creates software products for the medical industry to optimize and test medical treatments. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€5—7m (Dealroom.co estimates Dec 2021.)
Company register number B67260281
Barcelona Catalonia (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| Revenues | - | - | <1m | <1m | 2.3m |
| % growth | - | - | - | (20 %) | - |
| EBITDA | (<1m) | (<1m) | <1m | <1m | - |
| % EBITDA margin | - | - | 149 % | 262 % | - |
| Profit | (<1m) | (<1m) | <1m | (<1m) | - |
| % profit margin | - | - | 35 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
€10.0k | Grant | ||
N/A | Grant | ||
* | €1.2m | Seed | |
* | €2.5m | Grant | |
N/A | Early VC | ||
| Total Funding | €3.7m | ||
Related Content
Recent News about ELEM Biotech
EditMore about ELEM Biotech
EditDeveloper of a biomedical technology designed to transform medical innovation, preclinical and clinical testing. The company's technology facilitates the setting up and running of advanced simulations and analyzes them through a sophisticated biomedical interface, enabling companies to facilitate the diagnosis of diseases and the evaluation of treatments.
Keywords: Healthcare Devices, Services, Supplies, Biomedical Simulation Platform, Biomedical Simulation Service, Biomedical Therapy, Simulation Software, Simulation Software Platform, Virtual Humans Factory.